to his substernal area. Th e pain was associated with nausea, eructations, and a bad taste in his mouth, but he denied accompanying dyspnea or diaphoresis. Th e patient had received a drug-eluting stent approximately 12 years earlier. Subsequent cardiac catheterization 2 years prior to the present episode revealed a patent stent and no new coronary narrowing. His initial troponin I level was <0.05 g/dL, and his electrocardiogram revealed symmetric T wave inversions across the precordium (Figure 1 ). Given the atypical nature of his symptoms, the patient underwent a pharmacologic nuclear stress test using regadenoson, a vasodilator similar to adenosine. Following the intravenous administration of 0.4 mg (5 mL) of regadenoson, the patient began complaining of "not feeling well," and he was given 100 mg (4 mL, 25 mg/mL) of intravenous theophylline. Initial imaging demonstrated a large area of moderately reduced perfusion involving the ventricular septum, left ventricular distal anterior and inferior walls, and apex. Approximately 8 minutes into recovery, sudden severe substernal pain appeared. Electrocardiogram revealed ST segment elevation and hyperacute T waves in leads V 2 to V 4 ( Figure 2 ). Th e procedure was terminated immediately and the patient was taken to the cardiac catheterization laboratory. Serum drawn at that time revealed that the troponin I had risen to 0.3 ng/mL. Coronary arteriography revealed a long ulcerated lesion in a large left anterior descending coronary artery just beyond the takeoff of the fi rst diagonal. A drug-eluting stent was placed across the stenotic area without incident, and the patient had an uneventful recovery with complete resolution of his symptoms. He was asymptomatic when seen in follow-up a month after the procedure.
DISCUSSION
Exercise stress testing is frequently limited by the inability of individuals to elevate their heart rate to levels likely to induce myocardial ischemia. Accordingly, pharmacologic stress tests, most often using vasodilators, are employed as a substitute for the traditional exercise stress test. Exercise increases myocardial oxygen demand by increasing heart rate and blood pressure and produces ischemia in areas distal to coronary artery stenosis. In contrast, vasodilator pharmacologic stress tests cause myocardial ischemia by an entirely diff erent mechanism. Th e pharmacologic agents (dipyridamole, adenosine, or regadenoson) promote coronary vasodilatation through activation of A2A (primarily) and A2B adenosine receptors. Perfusion is increased to healthy well-perfused areas and, conversely, "stolen" away from the stenotic areas, which are already maximally vasodilated.
ST segment depression is the most common electrocardiographic abnormality encountered with stress testing, whether exercise or pharmacologic, and is thought to be indicative of subendocardial ischemia. Conversely, exercise-induced ST segment elevation is rare, occurring in 1.3% of patients (1), and may denote transmural ischemia. Exercise-induced ST segment elevation may also occur in the absence of ischemia in areas of previous myocardial infarction (with diagnostic Q waves and accompanying wall motion abnormalities) (2-4). In contrast to stress-induced ST segment depression, which tends to occur in the inferolateral electrocardiographic leads regardless of the site of coronary artery obstruction, exercise-induced ST segment elevation is usually localized to the area of ischemia (5, 6) . Vasodilator stress-induced ST segment elevation appears to be especially rare; review of the medical literature produced only two cases using dipyridamole (2, 7), three cases using adenosine (8) (9) (10) , and one recently reported case using regadenoson (11) . In all but one of these studies, coronary arteriography confi rmed >75% stenoses in at least one major coronary artery. It has been hypothesized that the lone case without signifi cant coronary artery disease may have been due to overexpression of A1 and A3 adenosine receptors (in comparison to A2 receptors), which have been shown to play an inhibitory role in the regulation of coronary blood fl ow (12, 13) . Our case is consistent with the limited experience in the literature and suggests that ST segment elevation in response to vasodilator stress may indicate a critical lesion requiring emergent coronary intervention. Our experience also emphasizes the need for continued close monitoring of these individuals until defi nitive measures can be taken.
